Back to Search
Start Over
The molecular determinants of calcium ATPase inhibition by curcuminoids.
- Source :
-
Biochimica et biophysica acta. Biomembranes [Biochim Biophys Acta Biomembr] 2024 Oct; Vol. 1866 (7), pp. 184367. Date of Electronic Publication: 2024 Jul 03. - Publication Year :
- 2024
-
Abstract
- The natural product curcumin and some of its analogs are known inhibitors of the transmembrane enzyme sarco/endoplasmic reticulum calcium ATPase (SERCA). Despite their widespread use, the curcuminoids' binding site in SERCA and their relevant interactions with the enzyme remain elusive. This lack of knowledge has prevented the development of curcuminoids into valuable experimental tools or into agents of therapeutic value. We used the crystal structures of SERCA in its E1 conformation in conjunction with computational tools such as docking and surface screens to determine the most likely curcumin binding site, along with key enzyme/inhibitor interactions. Additionally, we determined the inhibitory potencies and binding affinities for a small set of curcumin analogs. The predicted curcumin binding site is a narrow cleft in the transmembrane section of SERCA, close to the transmembrane/cytosol interface. In addition to pronounced complementarity in shape and hydrophobicity profiles between curcumin and the binding pocket, several hydrogen bonds were observed that were spread over the entire curcumin scaffold, involving residues on several transmembrane helices. Docking-predicted interactions were compatible with experimental observations for inhibitory potencies and binding affinities. Based on these findings, we propose an inhibition mechanism that assumes that the presence of a curcuminoid in the binding site arrests the catalytic cycle of SERCA by preventing it from converting from the E1 to the E2 conformation. This blockage of conformational change is accomplished by a combination of steric hinderance and hydrogen-bond-based cross-linking of transmembrane helices that require flexibility throughout the catalytic cycle.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Stefan Paula reports financial support was provided by National Institute of General Medical Sciences. Stefan Paula reports financial support was provided by National Science Foundation. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Binding Sites
Animals
Hydrogen Bonding
Crystallography, X-Ray
Enzyme Inhibitors chemistry
Enzyme Inhibitors pharmacology
Protein Binding
Curcumin chemistry
Curcumin pharmacology
Curcumin analogs & derivatives
Sarcoplasmic Reticulum Calcium-Transporting ATPases antagonists & inhibitors
Sarcoplasmic Reticulum Calcium-Transporting ATPases chemistry
Sarcoplasmic Reticulum Calcium-Transporting ATPases metabolism
Molecular Docking Simulation
Subjects
Details
- Language :
- English
- ISSN :
- 1879-2642
- Volume :
- 1866
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Biochimica et biophysica acta. Biomembranes
- Publication Type :
- Academic Journal
- Accession number :
- 38969202
- Full Text :
- https://doi.org/10.1016/j.bbamem.2024.184367